BiotechTube

PRX-100 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Presbyopia

Conditions

Presbyopia

Trial Timeline

Sep 1, 2015 → Nov 1, 2015

NCT ID
NCT02554396

About PRX-100 + Placebo

PRX-100 + Placebo is a phase 2 stage product being developed by LENZ Therapeutics for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT02554396. Target conditions include Presbyopia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02554396Phase 2Completed

Competing Products

14 competing products in Presbyopia

See all competitors
ProductCompanyStageHype Score
AGN-241622 + VehicleAbbViePhase 1/2
41
AGN-190584AbbVieApproved
85
AGN-190584 + VehicleAbbViePhase 3
77
UNR844 + PlaceboNovartisPhase 2
52
UNR844-Cl + PlaceboNovartisPhase 2
52
Pilocarpine Ophthalmic Topical Cream, Dose 1 + Pilocarpine Ophthalmic Topical Cream, Dose 2 + Pilocarpine Ophthalmic Topical Cream, Dose 3 + Placebo Ophthalmic Topical CreamGlaukosPhase 2
49
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
69
Aceclidine+tropicamide combination + Aceclidine + VehicleLENZ TherapeuticsPhase 2
44
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution + LNZ100 (Aceclidine) ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 1
25
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + VehicleLENZ TherapeuticsPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle proprietary ophthalmic solutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidineLENZ TherapeuticsPhase 3
69

Other Products from LENZ Therapeutics

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + VehiclePhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidinePhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionPhase 2
44